Back to News
Market Impact: 0.42

Stock Movers: Cisco, Doximity, and Nvidia (Podcast)

CSCODOCSNVDA
Artificial IntelligenceCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsHealthcare & BiotechTechnology & Innovation
Stock Movers: Cisco, Doximity, and Nvidia (Podcast)

Cisco shares jumped after the company issued fiscal Q4 revenue guidance of $16.7 billion to $16.9 billion, above the $15.8 billion consensus, and said it will cut thousands of jobs to concentrate on AI. Doximity slumped after giving a weaker-than-expected full-year forecast, with AI investments pressuring earnings and KeyBanc downgrading the stock to sector weight from overweight. Nvidia rose ahead of next week's earnings, helped by CEO Jensen Huang saying meetings with tech CEOs in Beijing 'went excellent.'

Analysis

CSCO’s move is less about a single quarter and more about a strategic repricing of the company from ex-growth networking incumbent to AI infrastructure participant. The workforce reduction matters because it signals management is willing to sacrifice near-term operating leverage to reallocate spend toward AI-related routing, security, and datacenter adjacency; that should improve the multiple if execution is credible, but it also raises the risk of margin disappointment over the next 2-3 quarters as restructuring charges and transition costs hit before revenue mix improves. The second-order beneficiary is the broader AI infrastructure stack: if Cisco can credibly guide to AI-related demand acceleration, it validates continued capex by hyperscalers and enterprises, which is incrementally positive for higher-beta network and optics names. The competitive risk is that AI spending may still accrue disproportionately to faster-moving platform vendors and specialized vendors, leaving Cisco with a narrative win but limited economic capture. In other words, the market may be overpaying for optionality unless bookings inflect by the next two reports. DOCS looks more vulnerable because AI investment is hitting a software business where payback is harder to prove and near-term earnings quality matters more than story. The bigger issue is that when a healthcare software name misses on guide due to AI spend, the market usually extrapolates to a broader “AI tax” across vertical SaaS, which can compress multiples across the group for 1-2 earnings cycles. If management cannot demonstrate that AI spend is expanding TAM or lowering CAC within the next 6-9 months, this becomes a classic spend-now, credibility-later problem. NVDA’s move is modest relative to event risk, which suggests the market is already assuming a high probability of a clean print next week. Positive commentary from China is tactically helpful, but the real catalyst is not sentiment; it is whether supply, export restrictions, and customer capex plans support another upside revision. The contrarian risk is that expectations are now so elevated that a merely good quarter could underwhelm, while any hint of channel digestion or constrained China contribution could trigger a sharp de-rating across AI semis for days to weeks.